These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33735799)

  • 1. Synthesis and evaluation of novel thiosemicarbazone and semicarbazone analogs with both anti-proliferative and anti-metastatic activities against triple negative breast cancer.
    Bai C; Wu S; Ren S; Zhu M; Luo G; Xiang H
    Bioorg Med Chem; 2021 May; 37():116107. PubMed ID: 33735799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
    Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
    Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of isoflavene-thiosemicarbazone hybrids and evaluation of their anti-tumor activity.
    Yee EMH; Brandl MB; Black DS; Vittorio O; Kumar N
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2454-2458. PubMed ID: 28408225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
    Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
    Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
    Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
    Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semicarbazone Derivatives Bearing Phenyl Moiety: Synthesis, Anticancer Activity, Cell Cycle, Apoptosis-Inducing and Metabolic Stability Study.
    Ma J; Ni X; Gao Y; Huang K; Wang Y; Liu J; Gong G
    Chem Pharm Bull (Tokyo); 2019 Apr; 67(4):351-360. PubMed ID: 30674756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of 4'-O-alkylamino-tethered-benzylideneindolin-2-ones as potent cytotoxic and apoptosis inducing agents.
    Senwar KR; Reddy TS; Thummuri D; Sharma P; Bharghava SK; Naidu VG; Shankaraiah N
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4061-9. PubMed ID: 27397498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
    Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
    Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
    Ding T; Yang LJ; Zhang WD; Shen YH
    J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
    Gao Z; Shi M; Wang Y; Chen J; Ou Y
    Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.
    Zhou Y; Lin S; Tseng KF; Han K; Wang Y; Gan ZH; Min DL; Hu HY
    BMC Cancer; 2016 Oct; 16(1):818. PubMed ID: 27769200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSi6 promotes cell death by apoptosis through cell cycle arrest and inhibits migration and invasion of MDA-MB-231 human breast cancer cells.
    Luna-Dulcey L; da Silva JA; Cominetti MR
    Anticancer Drugs; 2020 Jan; 31(1):35-43. PubMed ID: 31490285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Steroidal 5α,8α-Endoperoxide Derivatives with Semicarbazone/Thiosemicarbazone Side-chain as Apoptotic Inducers through an Intrinsic Apoptosis Pathway: Design, Synthesis and Biological Studies.
    Ma L; Wang H; Wang J; Liu L; Zhang S; Bu M
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32156024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sesquiterpene lactone analogues as potent anti-breast cancer agents.
    Nakagawa-Goto K; Chen JY; Cheng YT; Lee WL; Takeya M; Saito Y; Lee KH; Shyur LF
    Mol Oncol; 2016 Jun; 10(6):921-37. PubMed ID: 27055598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells.
    Medina-Reyes EI; Mancera-Rodríguez MA; Delgado-Buenrostro NL; Moreno-Rodríguez A; Bautista-Martínez JL; Díaz-Velásquez CE; Martínez-Alarcón SA; Torrens H; de Los Ángeles Godínez-Rodríguez M; Terrazas-Valdés LI; Chirino YI; Vaca-Paniagua F
    Invest New Drugs; 2020 Jun; 38(3):558-573. PubMed ID: 31177399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
    Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.